RISLENEMDAZ
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Small molecule | ANTAGONIST | Glutamate NMDA receptor; GRIN1/GRIN2B antagonist | no | 2 | 0 |
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Small molecule | ANTAGONIST | Glutamate NMDA receptor; GRIN1/GRIN2B antagonist | no | 2 | 0 |